Literature DB >> 2004812

Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.

D L MacLeod1, C L Gyles, A Valdivieso-Garcia, R C Clarke.   

Abstract

Purified Escherichia coli Shiga-like toxin II variant (SLT-IIv) was characterized with regard to selected physical, chemical, and biological properties. N-terminal amino acid sequencing confirmed the identities of 33,000-, 27,500-, and 7,500-molecular-weight (MW) bands seen on sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of purified SLT-IIv as the A subunit, A1 fragment, and B subunit, respectively. The arginine-serine bond between amino acids 247 and 248 in the A subunit was determined to be the site for proteolytic cleavage into A1 and A2 fragments. As with other SLTs, gel filtration chromatography of SLT-IIv gave estimates of the MW of holotoxin that were variable and less than predicted for a 1-A-subunit-5-B-subunit configuration. The MWs were estimated to be 40,000 and 43,000 by Sephacryl S-100 and Sephadex G-100 and less than 2,000 by Bio-Sil Sec-250 gel filtration chromatography. The isoelectric point of SLT-IIv holotoxin was 9.0. Cytotoxicity of SLT-IIv was destroyed by heating at 65 degrees C for 30 min and by incubation with 2-mercaptoethanol and dithiothreitol, but it increased 30-fold by incubation with trypsin, chymotrypsin, or pepsin and 2-fold by incubation with thermolysin. SLT-IIv cytotoxic activity was stable at neutral and alkaline pH values but was lost at pHs 3, 4, and 5. SLT-IIv was stable in fluid from the anterior and posterior small intestines of pigs but was not enterotoxic in pig intestinal loops. The smallest doses of SLT-IIv that inhibited protein synthesis in porcine endothelial cells and Vero cells were 0.1 ng and 0.1 fg, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004812      PMCID: PMC257842          DOI: 10.1128/iai.59.4.1300-1306.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Reproducible high yield sequencing of proteins electrophoretically separated and transferred to an inert support.

Authors:  M Moos; N Y Nguyen; T Y Liu
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

2.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Authors:  S E Richardson; M A Karmali; L E Becker; C R Smith
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

4.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease.

Authors:  M A Linggood; J M Thompson
Journal:  J Med Microbiol       Date:  1987-12       Impact factor: 2.472

6.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus.

Authors:  S B Calderwood; J J Mekalanos
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

8.  Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.

Authors:  F P Downes; T J Barrett; J H Green; C H Aloisio; J S Spika; N A Strockbine; I K Wachsmuth
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells.

Authors:  M P Moyer; P S Dixon; S W Rothman; J E Brown
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.

Authors:  B E Guth; E M Twiddy; L R Trabulsi; R K Holmes
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more
  5 in total

1.  Purification and partial immunochemical characterization of proteins of fimbriae F107 from Escherichia coli isolated from edema disease of pigs.

Authors:  J Rosocha; I Mikula; V Kalinácová; Z Kollárová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

2.  Sodium deoxycholate facilitates systemic absorption of verotoxin 2e from pig intestine.

Authors:  T E Waddell; C L Gyles
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  Characterization of F107 fimbriae of Escherichia coli 107/86, which causes edema disease in pigs, and nucleotide sequence of the F107 major fimbrial subunit gene, fedA.

Authors:  H Imberechts; H De Greve; C Schlicker; H Bouchet; P Pohl; G Charlier; H Bertschinger; P Wild; J Vandekerckhove; J Van Damme
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Interaction of verotoxin 2e with pig intestine.

Authors:  T E Waddell; C A Lingwood; C L Gyles
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

5.  Effects of zinc supplementation on Shiga toxin 2e-producing Escherichia coli in vitro.

Authors:  Ryoko Uemura; Tomoko Katsuge; Yosuke Sasaki; Shinya Goto; Masuo Sueyoshi
Journal:  J Vet Med Sci       Date:  2017-09-01       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.